
MOTS-C is a mitochondrial-derived research peptide available in the UAE, supplied as 32mg per pre-filled injection pen with published HPLC purity results.First characterised at USC in 2015, MOTS-C is encoded within the mitochondrial 12S rRNA gene, making it one of a small class of mitochondria-derived peptides. Preliminary findings from animal studies suggest MOTS-C activates the AMPK pathway in skeletal muscle, liver, and adipose tissue, influencing glucose uptake, fatty acid oxidation, and mitochondrial biogenesis.

